Assessing Severe COPD and Comorbidities in a 65-Year-Old Patient

This chapter delves into the assessment and management of a 65-year-old man with severe COPD, highlighting the limitations of FEV1 as a sole indicator of disease severity. The speakers explore the importance of considering comorbidities such as depression, diabetes, and lung cancer, emphasizing comprehensive care for improved outcomes. Topics include screening tools for comorbidities, optimizing treatment through pharmacologic and non-pharmacologic approaches, and the considerations for advanced therapies like lung volume reduction surgery.